Navigation Links
AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
Date:6/25/2013

IRVINE, Calif., June 25, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the initiation of a Phase 1 clinical trial with its lead compound, AHRO-001.  The Phase 1 study will evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

"There is a significant unmet need for effective and well-tolerated agents in the treatment of both atherosclerosis and lipid modulation," said Thomas W. Gardner, Chairman and Chief Executive Officer of AtheroNova.  "Based on AHRO-001's preclinical profile, we believe it has the potential to offer patients effective treatment for these chronic conditions with an improved therapeutic profile.  We look forward to assessing AHRO-001 in human trials and are extremely pleased to have met a significant milestone with transitioning into a clinical stage company."

The Phase 1 study is a randomized, double-blind, placebo controlled study that assesses ascending doses of AHRO-001 in healthy adult volunteers.  The program advanced into Phase 1 clinical testing following extensive successful preclinical studies with AHRO-001.

"This is clearly an exciting and transformative time for us," remarked Mark K. Wedel, MD, Chief Medical Officer of AtheroNova.

About AHRO-001

AHRO-001 is AtheroNova's first novel application for the treatment and prevention of atherosclerosis. Atherosclerotic plaque is the primary, underlying cause of heart disease and stroke in industrialized countries. AtheroNova has shown positive results in animal models for regression of pl
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AtheroNova Announces Milestone Filing of IND in Russian Federation
2. AtheroNova Receives Notice of Allowance for Its US Patent Application 12/024,908
3. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
4. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
5. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
6. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
7. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
8. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
9. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
10. ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
11. Romark Laboratories Initiates Phase 3 Trial of New Influenza Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015 Point-of-Care Partners, a ... consulting firm, has launched the ePA State Navigator ... IT vendors, payers and pharmacies to quickly assess ... authorization (ePA) of prescription medications. Today, ... are completed through time-consuming, manual processes amongst prescribers, ...
(Date:3/31/2015)... ROCHELLE, N.Y. , March 31, 2015 /PRNewswire-USNewswire/ ... it will be featured in the American Medical ... by ITN Productions. AMGA,s "High Performing ... on the challenges facing the nation,s healthcare system ... Medical Letter is profiled along with other leading ...
(Date:3/31/2015)... March 31, 2015 RnRMarketResearch.com ... market research report of 68 pages with latest ... intelligence library. The report "Pemphigus - Pipeline Review, ... therapeutic development for Pemphigus , complete with ... drug target, mechanism of action (MoA), route of ...
Breaking Medicine Technology:Point-of-Care Partners Launches the ePA State Navigator 2AMGA's High Performing Health News Program Features The Medical Letter 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
... , , ... Inc.,("Chindex") (Nasdaq: CHDX ), a leading independent American provider of ... that the Company will attend the 21st Annual Piper Jaffray,"Unplugged" Health ... the,New York Palace Hotel. , Management is ...
... SAN DIEGO, Nov. 24 Anadys Pharmaceuticals, Inc. (Nasdaq: ... 21st Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, ... conference is being held at The New York Palace Hotel. ... Anadys, will provide an overview of Anadys and its clinical ...
Cached Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2
(Date:4/1/2015)... San Francisco, CA (PRWEB) April 01, 2015 ... RxOrganics , and the international children’s medical charity, ... celebrate their new global partnership. , Campaign Details: ... their Rxmedical line to Operation Smile throughout ... amount based on such sales so that every order ...
(Date:4/1/2015)... Nike Golf Camps has expanded with ... and Florida. These programs are specifically designed for the ... a golf-intensive environment and to learn about the college ... Arizona coaching legend, Rick LaRose, spends significant time evaluating ... as it pertains to the recruiting and college search ...
(Date:3/31/2015)... Los Angeles, California (PRWEB) March 31, 2015 ... Caregiver Services has started to hire more caregivers, ... public relations personnel and care managers within the ... expansion the company's training institution, 1Heart Caregiver University ... to assist with its mission to provide quality ...
(Date:3/31/2015)... IL (PRWEB) March 31, 2015 As ... Chunk Fitness is pledging to have a mobile-friendly website ... This is part of Chunk Fitness’ continued commitment to ... its growing user base. All of the same great ... available; it will be substantially easier to read while ...
(Date:3/31/2015)... In conjunction with the Asbestos Awareness ... Mesothelioma Applied Research Foundation (Meso Foundation) announced the ... its existing work in mesothelioma research, education, support, ... Meso Foundation’s mission, we want to eliminate harmful ... asbestos, including mesothelioma,” said the Meso Foundation’s executive ...
Breaking Medicine News(10 mins):Health News:RxOrganics Forges Unique Partnership to Bring More Smiles to Underserved Global Heath Communities 2Health News:US Sports Camps and Nike Golf Camps to Host Golf Development Camps in Arizona and Florida 2Health News:US Sports Camps and Nike Golf Camps to Host Golf Development Camps in Arizona and Florida 3Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 3Health News:Mesothelioma Research Organization Announces New Prevention Program 2Health News:Mesothelioma Research Organization Announces New Prevention Program 3
... with disrupting mutations in the BRCA1 gene are known ... throughout their lives. Now, discoveries from an international research ... of those persons may possess additional genetic variants that ... appear in the current Nature Genetics . ...
... A new material could help surgeons more accurately locate ... minimize pre-surgical discomfort for patients. Microscopic gas-filled spheres of ... early-stage tumors to show their position using ultrasound imaging ... chemists, radiologists and surgeons at the University of California, ...
... in many ways, the latest technologies in the medical, ... older adults live better for longer. ... "UCLA Technology and Aging Conference: Science Changing Lives," will ... cutting-edge innovations affecting every aspect of life, from video ...
... HealthDay Reporter , FRIDAY, Sept. 17 (HealthDay News) -- ... act out aggressively are being given antipsychotic drugs in ... outbursts. It,s a trend that many parents ... a new study by researchers at New York,s Stony ...
... , This release is available in German ... only one of the consequences of intense urbanization. There is ... strong impact on ecosystems. To date, however, the more subtle ... not received enough attention. Scientists of the Max Planck Institute ...
... HealthDay Reporter , THURSDAY, Sept. 16 (HealthDay News) -- ... treat a low libido reported improvements in their sex ... powerful and somewhat mysterious mind-body connection surrounding arousal and ... the treatment of male sexual dysfunction in the late ...
Cached Medicine News:Health News:Mayo-led researchers discover genetic variants modifying breast cancer risk 2Health News:Better marker for breast cancer may reduce need for second surgeries 2Health News:UCLA conference to address technology's impact on successful aging Oct. 29 2Health News:UCLA conference to address technology's impact on successful aging Oct. 29 3Health News:UCLA conference to address technology's impact on successful aging Oct. 29 4Health News:UCLA conference to address technology's impact on successful aging Oct. 29 5Health News:Aggressive Kids With ADHD May Not Need Antipsychotic Meds 2Health News:Aggressive Kids With ADHD May Not Need Antipsychotic Meds 3Health News:Light is the friend of lovers 2Health News:Light is the friend of lovers 3Health News:Placebo Pill Gives Boost to Some Women's Sex Drive 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: